Expert Review of Pharmacoeconomics & Outcomes Research
期刊基本信息
期刊名称:Expert Review of Pharmacoeconomics & Outcomes Research
出版国家或地区:ENGLAND
是否OA:No
期刊ISSN:1473-7167
期刊官方网站:http://www.tandfonline.com/toc/ierp20/current
期刊投稿网址:https://mc.manuscriptcentral.com/erp
涉及的研究方向:HEALTH CARE SCIENCES & SERVICES-PHARMACOLOGY & PHA
期刊数据表:
最新中科院JCR分区
|
大类(学科)
小类(学科)
JCR学科排名
医学
HEALTH CARE SCIENCES & SERVICES(卫生保健科学和服务) 4区
PHARMACOLOGY & PHARMACY(药理学和药剂学) 4区
57/94
194/261
|
|||||||
最新的影响因子
|
2.032 | |||||||
最新公布的期刊年发文量 |
|
|||||||
总被引频次 | 1645 | |||||||
特征因子 | 0.003130 |
Expert Review of Pharmacoeconomics & Outcomes Research英文简介:
Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategiesFive-year view - a clear perspective of future prospects within a realistic timescaleKey issues - an executive summary cutting to the author's most critical points
Expert Review of Pharmacoeconomics & Outcomes Research中文简介:
《药物经济学与结果研究专家评论》(ISSN 1473-7167)提供有关药物临床使用和治疗方法的成本效益和药物经济学问题的专家评论。涵盖范围包括药物经济学和生活质量研究,治疗结果,循证医学和成本效益研究。所有的文章都要经过严格的同行评审。该杂志采用独特的专家评论文章格式,提供了一个关键技术领域、研究或临床实践的当前思想的完整概述,并辅以以下章节:专家评论-对最有效或最有前途的策略的个人观点五年展望——在一个现实的时间尺度内对未来前景的清晰展望关键问题-执行摘要削减到作者最关键的观点
Expert Review of Pharmacoeconomics & Outcomes Research在线问答:
SCI之家创始人研老师。创建SCI之家平台的初衷是为投稿国际期刊的朋友介绍相关的SCI、SSCI、EI、SCOPUS等国际学术刊物和国际学术动态。方便国内学者及时了解国际期刊的影响 因子、分区等学术动态,研老师有20年国际学术润色翻译经验相关经验,借助SCI之家平台为国内作者无偿分享英文论文的润色翻译、选刊、刊物对稿件要求等相关技巧。提高国际期刊的过稿录用率!